Android Artificial Pancreas System Use Among Patients With Type 1 Diabetes Mellitus in China - Trial NCT06081231
Access comprehensive clinical trial information for NCT06081231 through Pure Global AI's free database. This phase not specified trial is sponsored by Third Affiliated Hospital, Sun Yat-Sen University and is currently Recruiting. The study focuses on Type 1 Diabetes Mellitus. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Third Affiliated Hospital, Sun Yat-Sen University
Timeline & Enrollment
N/A
Jun 01, 2021
Aug 01, 2024
Primary Outcome
proportion of time spent in the target glucose range
Summary
This real-world prospective study will be conducted to reveal the current status of
 AndroidAPS use among patients with T1DM in China, evaluate the efficacy of AndroidAPS on
 glycemic outcomes, and explore the potential factors affecting the time in range(70-180mg/dL)
 derived from continuous glucose monitoring after AndroidAPS use.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06081231
Device Trial